You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'antigen'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 40.1 KDa. Observed: 45-55 KDa, reducing conditions
Human
Lys36-Asp161
C-mFc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.8 KDa. Observed: 65-80 KDa, reducing conditions
Human
Leu29Ala216
C-mFc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 43.9 KDa. Observed: 50-70 KDa, reducing conditions
Human
Leu24-Gln186
C-mFc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 86.4 KDa. Observed: 90-130 KDa, reducing conditions
Human
Asn29-Pro766
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45 KDa. Observed: 55-65 KDa, reducing conditions
Rhesus macaque
Met1-Leu158
C-Fc
500 μg, 1 mg, 10 μg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.9 KDa. Observed: 16-30 KDa, reducing conditions
Rhesus macaque
Met1-Leu158
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 50.5 KDa. Observed: 70-95 KDa, reducing conditions
Human
Val35-Leu242
C-mFc
1 mg, 10 μg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 57.2 KDa. Observed: 80-110 KDa, reducing conditions
Rhesus macaque
Pro20-Lys292
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38 KDa. Observed: 38-55 KDa, reducing conditions
Cynomolgus
Gln22-Asp117
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42 KDa. Observed: 50-60 KDa, reducing conditions
Human
Ile27-Ser159
C-Fc
10 μg, 50 μg, 500 μg, 1 mg